Trial reportNature medicine2026
Time-restricted eating for body weight management in women with polycystic ovary syndrome: a randomized controlled trial.
Trial report in Nature medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05629858 (Time Restricted Eating for the Treatment of Polycystic Ovarian Syndrome), which is not on this map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Time Restricted Eating for the Treatment of Polycystic Ovarian Syndrome (PCOS)
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic ovary syndrome (PCOS) is an endocrinological disorder characterized by weight-loss resistance. Time-restricted eating (TRE) has become a popular weight-loss tool. However, the efficacy of TRE for weight management in PCOS remains understudied. We evaluated the effectiveness of TRE compared with standard care (daily calorie restriction (CR)) and a no-intervention control in women with PCOS. Seventy-six participants were randomly assigned to one of three groups for 6 months: a 6-hour TRE regimen (all meals consumed between 1 p.m. and 7 p.m., without calorie tracking), a CR plan (25% daily energy restriction) or a control group with no dietary changes. The primary endpoint was percent change in body weight at 6 months. By month 6, body weight significantly decreased in the TRE group (-4.32% (95% CI, -6.20, -2.44), P < 0.01) and the CR group (-4.66% (95% CI, -7.13, -2.19), P < 0.01), relative to controls, with no difference between the TRE and CR groups (0.34% (95% CI, -2.15, 2.83), P = 0.79). No serious adverse events were reported. Our results show that in women with PCOS, TRE induced greater weight loss than the controls and was comparable to that achieved with daily CR. ClinicalTrials.gov registration: NCT05629858 .
Indexed as
Identifiers
41896647What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.